Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled treprostinil versus placebo crossover study in pulmonary hypertension associated with COPD
MOH_2020-05-27_008858Phase 3Completed
- Sponsor
- United Therapeutics Corporation
- Start
- Mar 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of treprostinil in Pulmonary hypertension associated with chronic obstructive pulmonary disease (COPD-PH) (2 arms), sponsored by United Therapeutics Corporation. Started Mar 2020; status: completed.
02
Drugs
treprostinil
03
Conditions
Pulmonary hypertension associated with chronic obstructive pulmonary disease (COPD-PH)
Beyond the preview
Go deeper on MOH_2020-05-27_008858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2020-05-27_008858.